Company Snapshat
Market Updates
>
Equity
>
Corporate Information
>
Company Snapshat
Back To Homepage
As on (17 Jul 2025 | 10:39)
Back To Homepage
As on (17 Jul 2025 | 10:39)
Daily Market Tracker
News
Corporate Information
Corporate Action
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Profit & Loss
Quarterly Results
Financial Ratios
Historical Price
Director's Report
Score Board
MF Holdings
Name Change
Company News
Beta Value
Peer Comparison
Prev Quarter Comparison
Dividend Details
Balance Sheet
Share Holding Pattern
Technical Charts
Details-quote
BSE
NSE
Caplin Point Laboratories Ltd
Pharmaceuticals - Indian - Formulations
BSE Code
524742
ISIN Demat
INE475E01026
Book Value
223.77
NSE Symbol
CAPLIPOINT
Div & Yield %
0.26
Market Cap (
₹
Cr.)
15813.85
P/E
46.58
EPS
44.66
Face Value
2
Stock price
Last Price (₹)
2,080.00
Best Buy (₹)
2101.2
Best Sell (₹)
2,104.70
Buy Quantity
11
Sell Quantity
7
Today's High (₹)
2,111.45
Today's Low (₹)
2,072.45
52-Week High (₹)
2636
52-Week Low (₹)
1426.05
Market statistics
Div & Yield %
0.26
Eps
44.66
Book Value
223.7724493
Market Cap(Rs.Cr)
15,813.85
Face Value
2
Market Lot
1
AGM Date
Sep
Book Closure Date
Sep
ISIN No.
INE475E01026
Chart
1 Day
5 Day
3 Mon
1 Yr
5 yr
News
Caplin Point Laboratories announces acquisition of Triwin Pharma S.A DE C.V
Board of Caplin Point Laboratories recommends dividend
Caplin Steriles receives USFDA approval for Haloperidol Decanoate Injection
Caplin Point Laboratories to conduct board meeting
Caplin Point Laboratories to conduct board meeting
Caplin Steriles receives USFDA approval for Phytonadione Injectable Emulsion
Caplin Steriles receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solu
Caplin Steriles receives USFDA approval for Procainamide Hydrochloride Injection
Caplin Point Laboratories to hold board meeting
Caplin Point Laboratories receives USFDA approval for Levetiracetam in Sodium Chloride Injection
<
P R E V
1
2
3
N E X T
>
Corporate Details
Incorporation Year :
1990
Chairman :
Business Group :
Registered Office :
Caplin Point Laboratories Ltd
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Chennai,
Tamil Nadu - 600096,
Phone : 91-44-24968000/71148000/28156653,
Fax : 91-44-28154952
E-Mail :
investor@caplinpoint.net; info@caplinpoint.net
URL :
http://www.caplinpoint.net
Date
Price
Returns (%)
1Week
09-Jul-2025
2032.10
2.38
1Month
16-Jun-2025
2095.50
-0.72
3Month
16-Apr-2025
1970.90
5.56
6Month
16-Jan-2025
2242.50
-7.23
1Year
16-Jul-2024
1530.75
35.91
Scheme Name
% Holding
Market Value
HDFC NIFTY Smallcap 250 ETF
0.21
2.77
Groww Nifty Total Market Ind..
0.02
0.07
Motilal Oswal BSE Healthcare..
0.31
0.10
HDFC BSE 500 ETF
0.02
0.00
AXIS Nifty 500 Index Fund
0.02
0.06